Andrew Hall - Austco Healthcare Chief Officer
| AHC Stock | 0.25 0.01 4.17% |
Executive
Andrew Hall is Chief Officer of Austco Healthcare
| Address | 31 Sabre Drive, Port Melbourne, VIC, Australia, 3207 |
| Phone | 61 3 9209 9688 |
| Web | https://austcohealthcare.com |
Andrew Hall Latest Insider Activity
Tracking and analyzing the buying and selling activities of Andrew Hall against Austco Healthcare stock is an integral part of due diligence when investing in Austco Healthcare. Andrew Hall insider activity provides valuable insight into whether Austco Healthcare is net buyers or sellers over its current business cycle. Note, Austco Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Austco Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Andrew Hall over six months ago Acquisition by Andrew Hall of 172500 shares of Goldman Sachs at 5.8 subject to Rule 16b-3 |
Austco Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.0736 % which means that it generated a profit of $0.0736 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.204 %, meaning that it generated $0.204 on every $100 dollars invested by stockholders. Austco Healthcare's management efficiency ratios could be used to measure how well Austco Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Austco Healthcare's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 7.6 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 9.1 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Angad Soin | Xero | N/A | |
| Mike Brock | Block Inc | N/A | |
| Ethan Settembre | CSL | N/A | |
| Sukhinder Cassidy | Xero | 54 | |
| BSc GAICD | CSL | 62 | |
| Karen ODriscoll | Cochlear | N/A | |
| Ajmere Dale | Block Inc | 54 | |
| Brian Kaplan | Cochlear | N/A | |
| Michael Strickman | Xero | N/A | |
| Dave Ross | CSL | N/A | |
| Christina Hickie | CSL | N/A | |
| Ashley Grech | Xero | N/A | |
| Narelle Lynch | Tamawood | N/A | |
| Nick Zangari | Light Wonder | N/A | |
| Sivan Whiteley | Block Inc | 47 | |
| Roanne Parry | CSL | 51 | |
| Andy Schmeltz | CSL | 53 | |
| MPH MD | CSL | 65 | |
| Nikhil Dixit | Block Inc | N/A | |
| MComm BE | Cochlear | N/A | |
| Alexander Schirmeister | Xero | N/A | |
Management Performance
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0736 |
Austco Healthcare Leadership Team
Elected by the shareholders, the Austco Healthcare's board of directors comprises two types of representatives: Austco Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Austco. The board's role is to monitor Austco Healthcare's management team and ensure that shareholders' interests are well served. Austco Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Austco Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Hall, Chief Officer | ||
| Michael Read, Gen Australasia | ||
| Brendan Maher, CFO Secretary | ||
| Clayton Astles, MD CEO | ||
| BBus ACA, CFO Secretary |
Austco Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Austco Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0736 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 77.42 M | ||||
| Shares Outstanding | 364.06 M | ||||
| Shares Owned By Insiders | 40.07 % | ||||
| Shares Owned By Institutions | 16.78 % | ||||
| Price To Book | 2.01 X | ||||
| Price To Sales | 1.53 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Austco Stock Analysis
When running Austco Healthcare's price analysis, check to measure Austco Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Austco Healthcare is operating at the current time. Most of Austco Healthcare's value examination focuses on studying past and present price action to predict the probability of Austco Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Austco Healthcare's price. Additionally, you may evaluate how the addition of Austco Healthcare to your portfolios can decrease your overall portfolio volatility.